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Objective: To describe health care utilization (HCU) and predict analgesic use and health professional (HP)
contact at baseline and 2 years in individuals with early symptomatic hip and/or knee osteoarthritis (OA).
Design: Baseline and two-year data on HCU of the 1002 participants from the multi-centre Cohort Hip &
Cohort Knee study were used. Six forms of health care services were described: analgesic use, supple-
ment use, contact with a General Practitioner (GP), contact with a HP, contact in secondary care, and
alternative medicine use. Multivariable logistic regression was performed in order to identify predis-
posing, enabling and disease-related variables that predict analgesic use and HP contact at 2 years;
treatment modalities of ﬁrst choice in early OA.
Results: For the hip (n¼ 170), the knee (n¼ 414) and the hip and knee (n¼ 418) group analgesic use (38%,
29% and 47%, respectively), contact with a GP (32%, 38% and 36%, respectively) and contact with a HP
(26%, 18% and 20%, respectively), were reported most often at baseline. Contact with a GP signiﬁcantly
decreased, supplement use increased (to about one third), and other treatment modalities remained
stable at 2 years. In all three groups, analgesic use at baseline was the strongest predictor for analgesic
use at 2 years, whereas contact with a HP at baseline was the strongest predictor of contact with a HP
after 2 years. Belonging to a ﬁrst generation minority was a predisposing risk factor [Odds Ratio (95%-CI),
8.72 (1.55e48.97)] for analgesic use in the hip and knee group.
Conclusions: In early OA, familiarity with HCU and other predisposing factors are, apart from disease-
related factors strongly associated with HCU at 2 years. Further research is necessary to examine
whether our ﬁndings reﬂect sub-optimal management of early OA in terms of efﬁcacy and equity.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Individuals with osteoarthritis (OA) often require long-term
access to a broad range of health care services1,2. Numerous
studies have shown high variability in the amount of health care
utilization (HCU) in people with OA3e13. Moreover, a number of
characteristics have been found to be cross-sectionally associated
with higher HCU in people with OA, including obesity, being single,: T.J. Hoogeboom, Maastricht
ology, Sint Maartenskliniek,
rlands. Tel: 31-24-327-2718;
(T.J. Hoogeboom).
s Research Society International. Phigher education level, pain, disabilities, depression, quality of life,
comorbidities and previous HCU3,4,7e12,14.
In current practice, OA is often under-diagnosed and under-
treated14,15 and patients who seek care early in their symptoms
might simply be told there is nothing to be done, or that their
symptoms are just part of the aging process. In our opinion,
however, patients in the earliest phase of the disease could and
should be adequately guided throughout the plethora of different
treatment options16. Therefore, insight into factors that predict use
of the health care system over time is important to allow health
care providers to intervene and possibly optimize patients’ use of
health care resources. To date, however, longitudinal research on
OA-related HCU is scarce17e19 and no data on predictors of futureublished by Elsevier Ltd. All rights reserved.
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current body of HCU evidence is the lack of studies describing
health care consumption of individuals with early OA.
Use of analgesics and contact with a health professional (HP) is
recommended in the early phase of OA16 and should be prescribed
in consonance with the patients’ needs. Andersen and Newman
state that access to health care depends on three types of factors:
predisposing, enabling, and disease-related factors20,21. Predispos-
ing factors refer to demographic and social characteristics. Enabling
resources reﬂect the ability to use care resources. Disease-related
factors represent the most immediate cause for HCU, reﬂected by
diagnosis, perception of illness, presence of symptoms, and
disability22. We hypothesize that both the use of analgesics and
contact with a HP are the most utilized treatment options and can
be predicted over time based on of disease-related factors in
patients with early symptomatic OA.
Therefore, the aims of this study were: 1) to describe HCU, and
2) to identify predictors for future use of analgesics and contact
with a HP in individuals with early symptomatic hip and/or knee
OA. To do so, we used baseline and two-year follow-up data from
the Cohort Hip & Cohort Knee (CHECK) study23.
Method
Design
Baseline and two-year follow-up data were used from the
CHECK cohort23. CHECK is a prospective cohort study of 1002
individuals with early symptomatic OA of hip or knee in The
Netherlands. These individuals will be followed prospectively for
a total period of 10 years. A total of 10 general and university
hospitals are participating in the study. Eligibility was determined
by physicians of participating centres. Study visits for all partici-
pants were planned at baseline and at two, ﬁve, eight and 10 years
and consist of structured interview, physical examination, radio-
logical assessment, serum- and urine-analysis, and questionnaires.
The study was approved by the medical ethics committees of all
participating centres, and all participants gave their written
informed consent. Data on self-report and physical examination at
baseline and two-year data on HCU from the CHECK cohort were
used for the current study.
Study population
On entry, all participants had pain or stiffness of hip or knee,
and were aged 45e65 years. All patients who visited the General
Practitioner (GP) on their own initiative and who potentially met
the inclusion criteria were referred to one of the 10 participating
centres. Additionally, participants were recruited through
advertisements and articles in the local newspapers and on the
Dutch Arthritis Association (DAA)-website. Participants with any
other pathological condition that could explain the symptoms
were excluded (e.g., other rheumatic disease, previous hip or
knee joint replacement, congenital dysplasia, osteochondritis
dissecans, intra-articular fractures, septic arthritis, Perthes’
disease, ligament or meniscus damage, plica syndrome, Baker’s
cyst)23.
At baseline, the majority of this cohort (83%) reported knee
symptoms23, of whom 76% fulﬁlled the clinical American College of
Rheumatology (ACR) criteria for the classiﬁcation of knee OA24. Hip
symptoms were reported by 59% of the cohort23, of whom 24%
fulﬁlled the clinical ACR criteria for the classiﬁcation of hip OA25.
Two-year follow-up data show an increase in these percentages, as
well as an increase in radiological signs. Therefore the CHECK
cohort can be considered as an “early” symptomatic OA cohort26.Measurement instruments
HCU (dependent variable)
An HCU questionnaire was developed based on the one devel-
oped by Patient Panel Chronic Diseases (The Netherlands Institute
for Health Services Research; NIVEL)27, and the questionnaire
Economic Aspects in Rheumatoid Arthritis28. Participants reported
whether or not they had visited health care providers during the
last 3 months or were hospitalized during the last year for their hip
and/or knee problems. All available OA-related health care services
were included: the GP, medical specialists (e.g., rheumatologist,
orthopaedic surgeon), HP (i.e., physiotherapy, occupational
therapy, exercise therapy, psychology), hospital stay, use of
analgesics (i.e., prescription and over-the-counter drugs) and/or
supplements (i.e., glucosamine and/or chondroitin), and comple-
mentary and alternative medicine (CAM) (e.g., acupuncture,
shiatsu massage, contact with a chiropractor, homeopathic medi-
cine, etc).
Baseline predictors (independent variables)
Patient characteristic (sociodemographic data, lifestyle factors)
and comorbidity were collected by use of a standardized
questionnaire.
Patient-reported outcome measures were determined by use of
validated questionnaires. Pain over the last week was measured
with a numeric rating scale (NRS, 0e10)29. Condition speciﬁc
health status was evaluated with the Western Ontario McMasters
University Osteoarthritis Index (WOMAC)30,31. WOMAC evaluates
three dimensions, Pain (0e20), Stiffness (0e8), and Functioning
(0e68), where higher scores represent worse health status.
Participants completed one WOMAC questionnaire for the hips
and knees overall. Self-reported health-related quality of life was
measured using the Short-Form 36 (SF-36) health survey32. The
SF-36 consists of eight subscales with a score range of 0e100,
where a score of 100 represents the best possible health situa-
tion. The Physical Component Scale (PCS) scores was calculated
and fatigue and distress were assessed with the vitality and
mental health subscale of the SF-36, respectively32. Coping
behaviour was measured with the Pain Coping Inventory33. Active
coping was deﬁned as the mean of three active strategies (pain
transformation, distraction, and reducing demands) and passive
coping as the mean of three passive strategy scores (retreating,
worrying and resting). Value of own health was assessed with the
visual analogue scale for health of the EuroQoL-5D question-
naire34. Social support was measured with the Dutch Social
Support Scale35.
Physical examination of the hip consisted of measuring range of
motion (ROM) (internal rotation and ﬂexion, in degrees), and pain
(yes/no) during internal rotation and ﬂexion. For the knee physical
examination consisted of ROM (ﬂexion-extension), pain during
ﬂexion, bony tenderness, effusion of the knee (reﬁll test), crepitus,
palpable warmth, and bony enlargement. The highest
KellgreneLawrence (K&L) Grading Scale score (range 0e4) of the
two hips and two knees36, was used as indicator for radiological
severity.
In Box 1 all baseline predictors are depicted according to the
classiﬁcation of Andersen and Newman20,21, namely predisposing
factors, enabling factors, and disease-related factors.
Statistical analysis
We performed all statistical analyses using STATA/IC 12.0. A hip
only group (n¼ 170), knee only group (n¼ 414) and hip and knee
group (n¼ 418) were deﬁned, based on self-reported joint pain by
the participants during the ﬁrst study visit. We described HCU at
Table I
Characteristics at baseline, presented for the hip only, knee only and, hip and knee
group
Hip only group Knee only group Hip and knee group
N 170 414 418
Age (mean (SD)) 55.7 (5.6) 56.1 (5.1) 55.8 (5.2)
Female 129 (76%) 317 (77%) 346 (83%)
BMI (median (IQR)) 25.2 (22.7e27.8) 25.6 (23.6e28.5) 25.5 (23.5e28.4)
Married/Partnership 137 (82%) 334 (83%) 340 (83%)
Education
Primary 2 (1%) 14 (3%) 9 (2%)
Secondary 111 (67%) 275 (69%) 296 (73%)
Higher education 53 (32%) 112 (28%) 102 (25%)
Highest K&L score
0 106 (63%) 247 (60%) 239 (57%)
1 37 (22%) 119 (29%) 139 (33%)
2 21 (13%) 41 (10%) 33 (8%)
3 4 (2%) 4 (1%) 6 (1%)
4 e e e
WOMAC (median (IQR))
Pain 4.8 (3.2) 4.5 (3.4) 5.7 (3.5)
Stiffness 2.5 (1.7) 2.5 (1.7) 2.9 (1.7)
Functioning 14.7 (11.1) 14.2 (11.0) 18.3 (12.2)
Abbreviations: eExclusion criteria; IQR, Inter-quartile Range; SD, Standard
Deviation.
Box 1. Baseline predictors categorized according to the
model of Andersen and Newman.
Predisposing factors
Age; Sex; BMI; Ethnicity; Marital State; Education;
Family Size, Work; Smoking; Alcohol consumption;
Coping Style (Active & Passive); Previous HCU.
Enabling factors
Dependency on others; Social Support; Health insurance
Disease-related factors
Number of comorbidities; Pain during last week;
Number of painful joints (hip/knee); WOMAC pain;
WOMAC stiffness, WOMAC functioning; EQ-vas; SF-36
mental health; SF-36 vitality; SF-36 Physical Component
Score; ESR.
Hip specific: Knee pain; ROM (Internal rotation); ROM
(Flexion); Pain during internal rotation; Pain during
flexion; Highest K&L grade hip.
Knee specific: Hip pain; Palpable warmth; Bony tender-
ness; Effusion; Bony enlargement; Crepitus; ROM
(Flexion þ Extension); Pain during flexion; Highest K&L
grade knee.
Abbreviations: BMI, Body Mass Index; EQ-vas, EuroQol
Visual Analogue Scale; ESR, Erythrocyte sedimentation
rate; HCU, Health Care Utilization; K&L, Kellgren and
Lawrence; ROM, Range of motion; SF-36, Short-Form 36,
WOMAC, Western Ontario and McMasters University
Osteoarthritis index.
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between baseline and 2 years were tested by use of McNemar tests
and differences between groups by use of KruskaleWallis test.
Complete-case data were used for all descriptive analyses.
To predict use of analgesics and contact with a HP in the hip
only, the knee only and hip and knee group at 2 years, we used
multivariable logistic modelling. Use of analgesics (yes or no)
comprised both prescription and over-the-counter drugs. Contact
with a HP (yes or no) was deﬁned as being in contact with a phys-
iotherapist, occupational therapist, or exercise therapist. First, we
studied the individual bivariate association of each independent
variable with the dependent variable by calculation of odds ratios.
Variables with a P-value 0. 15737 were removed and the
remaining variables were tested for collinearity by use of the
Variance Inﬂation Factor (VIF, cut-off> 10) statistic37. Subsequently,
multivariable logistic regression analyses were performed for the
remaining predisposing, enabling and disease-related factors
(P-value for removal <0.20). Finally, we entered the remaining
predictor variables as one block into a backward stepwise regres-
sion model (P removal 0.10) to come to the ﬁnal model. Finally,
Hosmer and Lemeshow goodness of ﬁt test, Area Under the
Receiver Operating Curve (AUC), and Nagelkerke’s R2 statistic were
calculated.
Logistic regression models with indicator variables for missing
values as outcome and the other variables as covariates38 showed
that missing data were not associated to observed values, indi-
cating that imputation of the missing values may reduce bias and
increase efﬁciency39,40. Multiple imputation using Imputation by
Chained Equation was used to estimate missing values41. A total of
10 different multiply imputed datasets were generated and ﬁnally
combined using Rubin’s rule of combination42. All logistic
regression analyses were performed on multiply imputed
datasets.Results
Study sample
Of the 1002 participants included in the CHECK cohort, 170
participants reported only hip complaints, 414 only knee
complaints and 418 both hip and knee complaints. A total of 982
(98%) participants completed and returned the baseline question-
naire and 932 (93%) participants returned the health service
questionnaire after 2 years. Seventy-four percent of the partici-
pants had complete data and 90% had less than three missing
values. Knee ROM and erythrocyte sedimentation rate (ESR) were
the independent variables with the largest number of missing
values; 9% and 5%, respectively. Characteristics of the study sample
are presented in Table I; for a more detailed description of the total
population, see Wesseling et al. (2008) 23.
HCU
The most frequently reported forms of health care use in the hip
only, the knee only and the hip and knee group at baseline were
analgesic use (38%, 29% and 47%, respectively), contact with a GP
(32%, 38% and 36%, respectively) and contact with a HP (26%, 18%
and 20%, respectively). In all groups, contact with a GP signiﬁcantly
decreased and supplement use signiﬁcantly increased at 2 years (all
P< 0.05). For other health care modalities (i.e., secondary care,
contact with a HP, analgesics and CAM) a standstill in use was
observed at 2 years in the hip only group and hip and knee group
compared with baseline. In the knee only group HP contact and
secondary care usewere signiﬁcantly decreased at 2 years (Table II).
Compared with the other groups, participants in the hip and
knee group reported signiﬁcantly more HCU (in particular use of
analgesics) at baseline and at 2 years. Between the hip only group
and knee only group no statistically signiﬁcant differences were
found (Table II).
Predictors for analgesic use
For the hip only group, multivariable logistic modelling yielded
two factors (one predisposing and one disease-related factor) that
independently (P< 0.05) predicted analgesic use at 2 years
(Nagelkerke’s R2: 0.47) (Table III). Having used analgesics before
Table II
HCU at baseline and 2 years for the hip only, the knee only, and the hip and knee group.*
Hip only group (n¼ 170) Knee only group (n¼ 414) Hip and knee group (n¼ 418)
HCU at T0 HCU at T2 No HCU at T0 & T2 HCU at T0 HCU at T2 No HCU at T0 & T2 HCU at T0 HCU at T2 No HCU at T0 & T2
Contact GP 32% 10% 61% 38% 11% 58% 36% 17% 57%
Contact secondary care 11% 11% 79% 14% 5% 84% 12% 8% 81%
Contact HP 26% 17% 66% 18% 12% 75% 20% 21%z 66%
Analgesics 38% 39% 52% 29% 31% 58% 47%x 50%x 38%
Supplementsy 18% 33% 62% 13% 31% 56% 17% 33% 62%
CAM 13% 8% 85% 6% 6% 91% 14%z 12% 80%
Abbreviations: T0¼ Baseline, T2¼ at 2 years.
* Numbers printed bold are signiﬁcantly different.
y Glucosamine/Chondroitin.
z Signiﬁcantly greater than the knee group.
x Signiﬁcantly greater than both the hip and knee group.
T.J. Hoogeboom et al. / Osteoarthritis and Cartilage 20 (2012) 525e531528and experiencing more problems in functioning (WOMAC) were
both signiﬁcant risk factors for analgesic use at 2 years.
For the knee only group, multivariable logistic modelling
resulted in one predisposing, one enabling, and one disease-related
factor (P< 0.05) that independently predicted analgesic use at 2
years (Nagelkerke’s R2: 0.35) (Table III). Risk factors for analgesic
use were previous analgesic use, dependency on others and having
a higher WOMAC pain score.
For the hip and knee group we identiﬁed two predisposing, one
enabling and four disease-related factors (P< 0.05) that indepen-
dently predicted analgesic use at 2 years (Nagelkerke’s R2: 0.40).
Risk factors were, previous analgesic use, having an active coping
style, belonging to a ﬁrst generation immigrant, having a higher
number of painful joints, experiencing bony tenderness and having
reduced hip ﬂexion (Table III).
Predictors for HP use
For the hip only group, one predisposing factor - previous
contact with a HP - (P< 0.05) was identiﬁed to independently
predict HP care use at 2 years (Nagelkerke’s R2: 0.08) (Table IV).Table III
Predictors for analgesics use for OA-complaints at 2 years
Hip only group
N 170
Predisposing factors
Paid work, yes e
Active coping e
Ethnicity
Majority e
First generation immigrant e
Second generation immigrant e
Analgesic use, t0 8.43*** [3.67, 19.39]
Enabling factors
Help by others, yes e
Health insurance
Public e
Private e
Private (government) e
Disease-related factors
No. of joint complaints (0e4) NA
WOMAC Pain e
WOMAC Functioning 1.07** [1.03, 1.12]
SF-36 PCS e
Bony Tenderness NA
Hip pain during int. rotation 2.70 [0.93, 7.83]
Hip ﬂexion e
Post-estimation results
AUC 0.85 [0.78, 0.92]
Nagelkerke’s R2 0.472
Hosmer e Lemeshow statistic 6.84, P> 0.05
Odds Ratio; 95% conﬁdence intervals in brackets. * P< 0.05, ** P< 0.01, *** P< 0.001. Abb
t0¼ baseline.For the knee only group, one predisposing and two disease-
related factors (P< 0.05) were identiﬁed for contact with a HP at
2 years (Nagelkerke’s R2: 0.17) (Table IV). Risk factors for contact
with a HP were: previous contact and a positive knee reﬁll test.
Lower level of distress (SF-36 mental health) was a protective
factor.
For the hip and knee group, two predisposing factors were
identiﬁed for contact with a HP at 2 years (Nagelkerke’s R2: 0.09).
Previous contact with a HP was a risk factor for contact with a HP at
2 years. Having a higher degree of educationwas a protective factor
(Table IV).
Discussion
In this longitudinal studywe found an overall low use of HCU for
the participants with early symptomatic hip and/or knee OA. At 2
years, supplement and analgesic use were most often reported. We
were unable to conﬁrm our hypothesis that HCU at 2 years was
primarily explained by disease-related factors, as the strongest
predictor for analgesic use and contact with a HP at 2 years was
previous use of these care modalities. In addition, several otherKnee only group Hip and knee group
414 418
0.64 [0.38, 1.09] e
e 2.45** [1.36, 4.42]
e (Reference)
e 8.72* [1.55, 48.97]
e 0.87 [0.28, 2.67]
4.69*** [2.73, 8.05] 5.33*** [3.16, 9.01]
7.08** [1.81, 27.78] e
(Reference) e
0.87 [0.33, 2.30] e
0.55 [0.31, 1.00] e
NA 1.30* [1.02, 1.67]
1.18*** [1.08, 1.28] e
e e
e 0.97** [0.94, 0.99]
e 1.76* [1.08, 2.85]
NA e
NA 2.16* [1.18, 3.95]
0.80 [0.75, 0.85] 0.83 [0.79, 0.87]
0.345 0.403
3.93, P> 0.05 7.57, P> 0.05
reviations: NA¼Not Applicable, No.¼Number of; PCS¼ Physical Component Scale;
Table IV
Predictors for contact with a HP at 2 years.
Hip only group Knee only group Hip and knee group
N 170 414 418
Predisposing factors
Contact with HP, t0 3.47** [1.43, 8.42] 4.15*** [2.04, 8.47] 2.82*** [1.61, 4.95]
Education, high e e 0.52* [0.27, 0.99]
Enabling factors
e e e e
Disease-related factors
No. of comorbidities (0e5) e e 1.20 [0.99, 1.46]
Pain during last week (VAS) e 0.84 [0.69, 1.02] e
WOMAC Stiffness e 1.22 [0.97, 1.53] e
SF-36 PCS e 0.96 [0.93, 1.01]
SF-36 Mental health e 0.97** [0.95, 0.99] e
Knee reﬁll e 2.67* [1.09, 6.50] e
Post-estimation results
AUC 0.64 [0.53, 0.74] 0.75 [0.68, 0.83] 0.67 [0.60, 0.73]
Nagelkerke’s R2 0.079 0.169 0.090
HosmereLemeshow statistic N/A 5.92, P> 0.05 3.22, P> 0.05
Odds Ratio; 95% conﬁdence intervals in brackets. * P< 0.05, ** P< 0.01, *** P< 0.001. Abbreviations: AUC¼Area Under the receiver operating characteristic Curve;
No.¼Number of; t0¼ baseline.
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associated with analgesic use or HP contact at 2 years.
As far as we know, we are the ﬁrst to identify baseline predictors
for future analgesic use and contact with a HP in individuals with
early hip or knee OA. Others have described health care
consumption over time in patients with (symptomatic) hip or knee
OA17e19. These studies generally reported substantially more health
consumption in people with OA than found in our study. These
differences are likely explained by differences in time frame of the
studies, samplingmethods andmanagement of OA among different
countries.
An interesting ﬁnding in our study was that supplement use
(i.e., glucosamine and chondroitin) was the only treatment
modality that had increased after two-year period. The CHECK
cohort was formed from 2002 to 2005 and glucosamine was
registered in The Netherlands as an over-the-counter drug in 2005,
although it was available before that. This registration, however,
hardly increased overall supplement use during that period in The
Netherlands. Another hypothesis for this increase could be that
patients try other, more alternative forms of care after experiencing
disappointing results from conventional treatments. However, this
explanation is questionable, since other forms of alternative care
had decreased at 2 years. A ﬁnal hypothesis could be that GPs
dismiss their patients’ OA symptoms as mere pains and aches of
aging and therefore would not embark on a well-thought out,
individualized treatment plan. The latter was also (partly)
demonstrated by the decrease/standstill in HCU after 2 years. Lack
of a clear treatment plan could leave patients unattended in their
needs and as a result leave patients searching for easily accessible
forms of health care (e.g., supplements). Additional long-term
observation of supplement use in the CHECK cohort will reveal
whether this increase is persistent.
We identiﬁed that being a ﬁrst generation minority was a risk
factor for analgesic use in the hip and knee group, but not in the hip
only and knee only group. Literature ﬁndings demonstrate that
minority groups with OA more frequently use over-the-counter
drugs than Caucasian people43. At this moment we have no satis-
factory explanation for the differences in our study between
subgroups of patients. However, in our view our ﬁndings suggest
potential racial disparities in medication use that warrant further
research.
Our ﬁndings give reason to re-evaluate the current practice in
people with OA, as we believe there is room for improvement. First,
supplement use was the only health care modality that hadincreased at 2 years and approximately 10% of the participants
reported the use of CAM in earliest stage of the disease, whilst the
effectiveness of such interventions are under debate44. Using these
forms of therapy will most likely result in high therapy costs,
disappointing therapy results and (unnecessary) risks for adverse
events. Second, as mentioned in the previous paragraph, people
belonging to minority groups might receive sub-optimal prescrip-
tion of analgesics, indicating inequity of health care prescription in
the management of OA. Third and ﬁnal, our results suggest that
factors other than disease-related factors (e.g., previous use of
a therapy modality) are associated with contacts with HPs or use of
analgesics, indicating that health status is not the primary deter-
minant associated with these treatment modalities. Considering
these three issues, we believe that patients should be guided
throughout the plethora of health care modalities. Some potentially
useful projects aiming to deliver optimal primary care have already
been initiated, such as the Beating OA16 and the MOSAICS project
(ISRCTN06984617).
The strengths of our study include the large sample size, the
participation of 10 different centres and the high response and
retention rates. In addition, the amount of missing data was small.
Limitations include the reliance on self-report data with regard to
HCUwhichmay have induced recall bias andmost likely resulted in
over-reporting45. Also, participants may have perceived the contact
with the study assessor (physiotherapist or clinician) as health care
consumption, which could also have resulted in a over-reporting of
health care contacts. A second limitation is that participants in the
CHECK cohort may have regarded the CHECK visits as a substitute
for contacts with other care providers, thus possibly resulting in
less utilization of health care. Finally, the cohort is limited to The
Netherlands, which affects the study’s generalizability due to its
speciﬁc health care system. In The Netherlands, GPs are accessible
to everyone since basic health insurance is mandatory. Dutch
primary care, with gate-keeping GPs at its core, prevents unnec-
essary use of more expensive secondary care and promotes
consistency and coordination of individual care. It is likely that the
results in this study are particularly generalizable to countries with
a similar health care system, such as the United Kingdom, Spain,
Finland and Italy.
In conclusion, individuals with early symptomatic OA rely in the
ﬁrst 2 years mainly on analgesics, with approximately one third
trying supplements at 2 years. We demonstrated that predisposing
factors (such as education, ethnicity and familiarity with care) are
strongly associated with HCU, whereas one would presume
T.J. Hoogeboom et al. / Osteoarthritis and Cartilage 20 (2012) 525e531530disease-related factors to be leading in the utilization of care. The
latter suggests that HCU should be optimized by taking the health
needs of patients in OA into consideration and by minimizing the
inﬂuence of predisposing factors.
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